Do you know that lung cancer kills most among other forms of cancer and just around five percent of the patients survive for more than five years? Up till now all efforts to come with a solution for this menace have failed and this disease has not seen any change in the death rate for more than a decade. This trend could change as an experimental drug has been discovered which could lengthen the lives of lung cancer patients by a third. The experimental drug has been discovered by Antisoma which is a UK biotechnology company and it works by destroying blood vessels which supply solid tumors on which the tumors depend for survival and growth. Up till now the drug has shown satisfactory results.